Insights from 2023 IMS Annual Meeting

 

Insights from 2023 IMS Annual Meeting
G

IMS 2023 Insights: "Post-Induction Undetectable Flow MRD Ameliorates the High Risk Determined by FISH Among NDMM"

By Insights from 2023 IMS Annual Meeting FEATURING Güldane Seval
By Insights from 2023 IMS Annual Meeting FEATURING Güldane Seval
0 views
November 6, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Featured Video

24:35
Indy Hematology Review

Current Approaches in the Treatment of Myeloproliferative Neoplasms

Feat. A. Tefferi
Videos
18:30
Insights from 2023 IMS Annual Meeting

ASH 2023 Insights: "Emapalumab for Treatment of Impending Graft…

Feat. A. Sabulski
05:08
Insights from 2023 IMS Annual Meeting

IMS 2023 Insights: "Applicability of the R2-ISS Staging System …

Feat. J. Bila
13:18
Insights from 2023 IMS Annual Meeting

Highlights and Key Takeaways From the 2023 International Myeloma Soc…

Feat. A. Jakubowiak
05:53
Insights from 2023 IMS Annual Meeting

IMS 2023 Insights: "Post-Induction Undetectable Flow MRD Amelio…

Feat. G. Seval
08:48
Insights from 2023 IMS Annual Meeting

IMS 2023 Insights: "Isa-KRd in High-Risk NDMM - Planned Interim…

Feat. L. Leypoldt
09:00
Insights from 2023 IMS Annual Meeting

IMS 2023 Insights: "Time to Tailor? Treatment Selection at Firs…

Feat. M. Delforge
10:33
Insights from 2023 IMS Annual Meeting

IMS 2023 Insights: "Early Outcomes & Therapy Modification S…

Feat. S. Kumar
07:22
Insights from 2023 IMS Annual Meeting

IMS 2023 Insights: "Time for T? Expanding Treatment Paradigms i…

Feat. R. Mina
06:17
Oncology Data Advisor

Linvoseltamab for R/R MM: LINKER-MM1 Trial Results From IMS 2023

Feat. M. Dhodapkar
10:13
Insights from 2023 IMS Annual Meeting

IMS 2023 Insights: "Serial MRD Assessments as a Surrogate for L…

Feat. F. van Rhee
16:07
Insights from 2023 IMS Annual Meeting

IMS 2023 Insights: "What Is the Ideal Duration of Treatment in …

Feat. K. Yong
09:19
Insights from 2023 IMS Annual Meeting

IMS 2023 Insights: "Optimizing Supportive Care Management in Ne…

Feat. E. Terpos
13:32
Insights from 2023 IMS Annual Meeting

IMS 2023 Insights: "Second Primary Malignancies After Tandem aH…

Feat. S. Al Hadidi
11:31
Insights from 2023 IMS Annual Meeting

IMS 2023 Insights: "Epigenetic Drivers of Disease Progression i…

Feat. F. Prosper
03:17
Insights from 2023 IMS Annual Meeting

IMS 2023 Insights: "Highlights From the International Myeloma S…

Feat. J. Richter
22:17
Insights from 2023 IMS Annual Meeting

IMS 2023 Insights: "Unraveling the Myeloma Proteome"

Feat. A. Wiita
09:52
Insights from 2023 IMS Annual Meeting

IMS 2023 Insights: "Epigenetic Regulation of CD38/48 by KDM6A a…

Feat. J. Liu
07:11
Insights from 2023 IMS Annual Meeting

IMS 2023 Insights: "Final Survival Outcomes From the Ph3 OPTIMI…

Feat. M. Beksaç